These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17652008)

  • 1. Chemotherapy of schistosomiasis: present and future.
    Caffrey CR
    Curr Opin Chem Biol; 2007 Aug; 11(4):433-9. PubMed ID: 17652008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current drug strategies for the treatment and control of schistosomiasis.
    Villamizar-Monsalve MA; López-Abán J; Vicente B; Peláez R; Muro A
    Expert Opin Pharmacother; 2024 Mar; 25(4):409-420. PubMed ID: 38511392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosomiasis: from drug deployment to drug development.
    Caffrey CR; Secor WE
    Curr Opin Infect Dis; 2011 Oct; 24(5):410-7. PubMed ID: 21734570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of repeated treatment with praziquantel and arthemeter in four patients with acute schistosomiasis.
    Praticò L; Mariani B; Brunetti E; Maserati R; Bruno A; Novati S; Chichino G
    J Travel Med; 2014; 21(2):133-6. PubMed ID: 24455977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanism of Action of Praziquantel: Can New Drugs Exploit Similar Mechanisms?
    Thomas CM; Timson DJ
    Curr Med Chem; 2020; 27(5):676-696. PubMed ID: 30259811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria.
    Inyang-Etoh PC; Ejezie GC; Useh MF; Inyang-Etoh EC
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):38-44. PubMed ID: 18838149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.
    Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D
    Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric and maternal schistosomiasis: shifting the paradigms.
    Bustinduy AL; Stothard JR; Friedman JF
    Br Med Bull; 2017 Sep; 123(1):115-125. PubMed ID: 28910994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinins for schistosomiasis and beyond.
    Utzinger J; Xiao SH; Tanner M; Keiser J
    Curr Opin Investig Drugs; 2007 Feb; 8(2):105-16. PubMed ID: 17328226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous schistosomiasis. Apropos of a case].
    Mathelier-Fusade P; Beaulieu-Lacoste I; Cailliez D; Audebert C
    Ann Dermatol Venereol; 1991; 118(10):715-7. PubMed ID: 1781591
    [No Abstract]   [Full Text] [Related]  

  • 15. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of praziquantel therapy on the histopathological and parasitological aspects of experimental schistosomiasis mansoni.
    El-Hawey A; Masoud A; Metwally A; El Badrawy N; El Garam A; Roushdi M; Khalil A
    J Egypt Soc Parasitol; 1983 Dec; 13(2):613-24. PubMed ID: 6663121
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.
    Yepes E; Varela-M RE; López-Abán J; Rojas-Caraballo J; Muro A; Mollinedo F
    PLoS Negl Trop Dis; 2015; 9(7):e0003893. PubMed ID: 26191954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren.
    De Clercq D; Vercruysse J; Kongs A; Verlé P; Dompnier JP; Faye PC
    Acta Trop; 2002 Apr; 82(1):61-6. PubMed ID: 11904104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.
    Doenhoff MJ; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):199-210. PubMed ID: 16597202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.